SANGAMO THERAPEUTICS, INC. — Revenue by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/f92ed8db-e183-49b4-9af2-13e16021d544/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $39.6M | 2025-01-01 – 2025-12-31 | evidence 0001628280-26-022029 |
| FY 2024 | $57.8M | 2024-01-01 – 2024-12-31 | evidence 0001628280-25-013088 |
| FY 2023 | $176.2M | 2023-01-01 – 2023-12-31 | evidence 0001628280-24-010788 |
| FY 2022 | $111.3M | 2022-01-01 – 2022-12-31 | evidence 0001628280-23-004666 |
| FY 2021 | $110.7M | 2021-01-01 – 2021-12-31 | evidence 0001628280-22-003819 |
| FY 2020 | $118.2M | 2020-01-01 – 2020-12-31 | evidence 0001628280-21-003069 |
| FY 2019 | $102.4M | 2019-01-01 – 2019-12-31 | evidence 0001628280-20-002582 |
| FY 2018 | $84.5M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-005808 |
| FY 2017 | $36.6M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-005808 |
| FY 2016 | $19.4M | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-005808 |
| FY 2015 | $39.5M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-012882 |
| FY 2014 | $45.9M | 2014-01-01 – 2014-12-31 | evidence 0001564590-15-000950 |
| FY 2013 | $24.1M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-065170 |
| FY 2012 | $21.7M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-076887 |
| FY 2011 | $10.3M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-073470 |
| FY 2010 | $20.8M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-073470 |
| FY 2009 | $22.2M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-073470 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
SANGAMO THERAPEUTICS, INC. — all facts · Net Income · Operating Income